SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-039076
Filing Date
2022-06-24
Accepted
2022-06-24 06:30:42
Documents
2
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2795
2 POA DOCUMENT poa.txt EX-24 3440
  Complete submission text file 0001209191-22-039076.txt   7621
Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
FAMBROUGH DOUGLAS (Reporting) CIK: 0001259856 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39575 | Film No.: 221036902

Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Issuer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations